Matthew Trojan, MD, joined the staff of Oregon Cardiology and OHVI in 2007. His specialty is care of the patient with advanced heart failure. Dr. Trojan was formerly from the University of Virginia, in Charlottesville, where, after a cardiology fellowship, he pursued advanced training and experience in congestive heart failure, transplant medicine, and electrical device therapy. He also served as a clinical instructor. He graduated from Emory University School of Medicine, in Atlanta, in 1999, and completed his internal medicine residency at the University of Minnesota Medical Center, in Minneapolis. He was board certified by the American Board of Internal Medicine in 2002 and again in 2006 in cardiovascular diseases. Dr. Trojan has served as an investigator on a number of clinical trials, including studies on cardiac resynchronization therapy with CRT-D devices and the efficacy of 3,5-diiodothyropropionic acid (DIPTA) for patients with congestive heart failure. An All-American swimmer in 1994, Dr. Trojan still enjoys recreational cycling.